Skip to content

Clinical trials

Phase 3 Hypertension, Portal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Portal Phase: Phase 3 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20064
20081
20103
20141
20152
20181
20191
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status6
Withdrawn2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Aga Khan University1
Alexandria University1
Debiovision1
Guangxi Medical University1
Hospital Universitari Vall d'Hebron Research Institute1
Hvidovre University Hospital1
Juan A. Arnaiz1
Laikο General Hospital, Athens1
Rutgers, The State University of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Portal21
Fibrosis10
Esophageal and Gastric Varices8
Liver Cirrhosis6
Liver Diseases4
Varicose Veins3
Carcinoma, Hepatocellular2
Ascites1
Gastrointestinal Hemorrhage1
Hematemesis1

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.